Back to trial details

Intake questionnaire

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

Applying to The University of Texas MD Anderson Cancer Center · Houston, Texas

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Plasmablastic Lymphoma?
3. Are you able to travel to Houston for study visits?